Oriana Ciani
Overview
Explore the profile of Oriana Ciani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tereshchenko L, Manyara A, Ciani O, Sodeke S, Bradford C, Santangeli P, et al.
Heart Rhythm
. 2025 Feb;
PMID: 40021073
In this call for transparency, we aim to disseminate knowledge about recent CONSORT-Surrogate and SPIRIT-Surrogate checklists. SPIRIT-Surrogate is an extension of the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)...
2.
Faria C, Polese J, Manyara A, Taylor R, Ciani O, Scianni A
J Physiother
. 2024 Dec;
71(1):1-3.
PMID: 39690082
No abstract available.
3.
4.
Generali D, Rocca A, Strina C, Milani M, Fiorino E, Cervoni V, et al.
Heliyon
. 2024 Nov;
10(21):e39485.
PMID: 39553665
Purpose: The aim of this study was to assess the prognostic performance of the 70-gene signature, MammaPrint, in an Italian single-center prospective cohort of early-stage intermediate-risk breast cancer (BC) patients....
5.
Bertolaccini L, Ciani O, Lucchi M, Zaraca F, Bertani A, Crisci R, et al.
JMIR Res Protoc
. 2024 Oct;
13:e67629.
PMID: 39471369
[This corrects the article DOI: 10.2196/57183.].
6.
Ardito V, Ciani O, Drummond M
Pharmacoeconomics
. 2024 Oct;
43(1):5-29.
PMID: 39405025
Background And Objective: In a context of growing clinical and financial uncertainty, pricing and payment schemes can act as possible solutions to the problems of affordability and access to health...
7.
Bertolaccini L, Ciani O, Lucchi M, Zaraca F, Bertani A, Crisci R, et al.
JMIR Res Protoc
. 2024 Oct;
13:e57183.
PMID: 39378423
Background: Lung cancer, predominantly non-small cell lung cancer (NSCLC), remains a formidable challenge, necessitating an in-depth understanding of evolving treatment paradigms. The Italian Lung Cancer Observational Study (LUCENT) addresses this...
8.
Valsecchi A, Giovanardi F, Malandrini F, Meregaglia M, Servetto A, Bennati C, et al.
Breast
. 2024 Oct;
78:103817.
PMID: 39362075
Background: Inclusion of patient-reported outcomes (PROs) in oncology clinical trials is strongly recommended. However, selecting the most appropriate patient-reported outcome measures (PROMs) is not easy. This study aimed to develop...
9.
Borsoi L, Listorti E, Ciani O
Pharmacoecon Open
. 2024 Sep;
8(6):945-959.
PMID: 39264499
Background: Shared decision-making (SDM) plays a crucial role in breast cancer care by empowering patients and reducing decision regret. Patient decision aids (PtDAs) are valuable tools for facilitating SDM, now...
10.